Inogen, Inc. (INGN) Q4 2025 Earnings Call Transcript

Inogen, Inc. (INGN) Q4 2025 Earnings Call Transcript

Seeking Alpha • 15 minutes ago

Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook.

Business Wire • 5 hours ago

Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates

Inogen (INGN) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $0.41 per share a year ago.

Zacks Investment Research • an hour ago

Inogen Announces $30 Million Share Repurchase Program

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces $30 Million Share Repurchase Program.

Business Wire • 5 hours ago

Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Feb 17, 2026

Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock?

Inogen (INGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Investment Research • Feb 12, 2026

Inogen (INGN) Loses 10.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Inogen (INGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks Investment Research • Feb 10, 2026

Here's Why You Should Add Inogen Stock to Your Portfolio Now

INGN looks poised as Q3 revenue rises 4%, POC demand grows and valuation is low, despite seasonal softness.

Zacks Investment Research • Feb 2, 2026

Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025

GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026.

Business Wire • Jan 12, 2026

INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite

Inogen launches Aurora CPAP masks to expand its respiratory care suite and enter the growing sleep apnea market.

Zacks Investment Research • Jan 8, 2026